Shannon T. Kelley, General Counsel of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), filed a Form 4 on August 20, 2026, reporting a sale of 664 shares of common stock on August 17, 2026.

Key Highlights

  • Reporting person: Shannon T. Kelley, General Counsel of Madrigal Pharmaceuticals, Inc.
  • Transaction: 664 shares of common stock disposed of (transaction code S) on August 17, 2026
  • Price per share: $514.97
  • Purpose of sale: Shares were sold by the issuer on behalf of the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units, and the sale was described as automatic and not at the discretion of the reporting person
  • Remaining holdings: 11,474 shares of common stock beneficially owned directly following the transaction

Tax Withholding Sale by Madrigal Pharmaceuticals General Counsel

According to the Form 4 filed with the SEC on August 20, 2026, Shannon T. Kelley, serving as General Counsel of Madrigal Pharmaceuticals, Inc., reported the disposition of 664 shares of common stock at a price of $514.97 per share. The transaction date was August 17, 2026, and the transaction was recorded under code "S," indicating a sale in the open market.

The filing includes a footnote clarifying the nature of the transaction: "This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person." Following this transaction, Kelley directly beneficially owns 11,474 shares of Madrigal Pharmaceuticals common stock, according to the filing.

The Form 4 was signed by Mardi Dier as Attorney-in-Fact on August 20, 2026. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

Shannon T. Kelley, General Counsel of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), reported an automatic sale of 664 shares of common stock at $514.97 per share on August 17, 2026, to satisfy tax withholding obligations tied to vesting restricted stock units, leaving a remaining direct holding of 11,474 shares.